Brain Device Articles & Analysis
25 news found
This extra fluid puts pressure on the brain and can cause brain damage. Hydrocephalus is characterized by head enlargement in infants. Treatment is often a tube (shunt) inserted surgically into a ventricle of the brain to drain excess fluid, but over time the device can often become dislodged or clogged which then requires more ...
This procedure represents a significant technological milestone for scalable BCI devices and is the first to occur in the U.S. using an endovascular BCI approach, which does not require invasive open-brain surgery. ...
” Relivion is a non-invasive brain neuromodulation device that is placed around the head and delivers stimulation to the occipital and trigeminal nerves. This creates a cumulative effect by releasing neurotransmitters in the brainstem and modulating brain networks associated with control of pain and mood. The device is ...
“Our research is exciting because while other devices require surgery that involves opening the skull, this brain-computer interface device is much less invasive. ...
NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA Breakthrough Device Designation for its Monarch eTNS System® for “adjunctive use for reducing the frequency of seizures in individuals 18 years of age or older diagnosed with epilepsy characterized by partial-onset seizures, with or without secondary generalization, that are ...
” Synchron has developed an endovascular brain computer interface that is designed to access every corner of the brain using its natural highways, the blood vessels. ...
First Quarter and Recent Business Updates Submitted clearance request to FDA for less than 30-day use of NeuroOne's Evo® sEEG Electrode, which has already been 510(k) cleared for temporary (less than 24 hours) use Exhibited our Evo cortical electrode product family at the American Epilepsy Society Meeting in Zimmer Biomet's booth Presented poster with the following title at American ...
We will be working with Leuko to help with the development of their fast, portable and simple to use device. Their aim is that millions of immunosuppressed patients can use PointCheck™ for frequent testing, thus removing the need for a blood draw. ...
Now, the Montreal-based company that Petrecca helped found is poised to solve the problem of residual brain cancer. Reveal Surgical is taking aim at glioblastomas, the most common and fatal type of malignant brain tumour. ...
The main findings of the study included: CGuard MicroNet-covered carotid stent, in relation to a first-generation stent: reduced 4.5-fold the magnitude of peri-procedural silent brain infarcts volume; and abolished post-procedural silent infarcts, that were on-going with the first-generation stent. ...
Brain-assessment device innovator BrainScope, and Aon plc (NYSE: AON), a leading global professional services firm, today announced the completion of an intellectual property-based funding arrangement. ...
It is the first medical device cleared for brain tumor treatment in the U.S. in the last ten years. ...
Synchron, a venture-backed brain data transfer company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application for its flagship product, the Stentrode™ motor neuroprosthesis. ...
People recovering from a stroke will soon have access to a device that can help restore a disabled hand. The Food And Drug Administration has authorized a device called IpsiHand from the uninjured side of a patient's brain to help rewire circuits controlling the hand, wrist and arm. ...
In order to support clinical effectiveness and clinical decision making, Oxford Brain Diagnostics will examine a total of 300 patient MRI scans. CDM® will be used to distinguish patient cohorts and measure changes in brain structure across time points. ...
FDA Breakthrough Device Designation Neurolutions, Inc., a medical device company developing and commercializing a first-of-its-kind device leveraging brain-computer interface (BCI) technology for upper extremity chronic stroke rehabilitation, announced today that the U.S. ...
The Neurolutions IpsiHand Upper Extremity Rehabilitation System (IpsiHand System) is a Brain-Computer-Interface (BCI) device that assists in rehabilitation for stroke patients with upper extremity—or hand, wrist and arm—disability. ...
Neurolief Ltd., a neurotechnology innovator, today announces that it has entered into an exclusive agreement with Sawai Pharmaceutical Co., Ltd. for the development and marketing of Relivion®, a non-invasive digital medical device for migraine and depression, in Japan. Relivion® is a non-invasive brain neuromodulation* device that is ...
Oxford Brain Diagnostics Ltd, a spinout from the University of Oxford specialising in the measurement of neurodegeneration in Alzheimer’s disease, today announces that the US Food and Drug Administration (FDA) has awarded Breakthrough Device Designation to its Cortical Disarray Measurement (CDM®) Software Device for evaluating adults at ...
Accessing an FDA compliant EEG device that performs at an uncompromising standard, allows for increased throughput and provides a user experience that rivals the latest technology assets, was very attractive to us. ...